Carboplatin-gemcitabine in the therapy of advanced ovarian cancer: Dose reduction consideration

Journal of Oncology Pharmacy Practice

Volumn 16, Issue 1, 2010, Pages 63-66

  Dasanu, Constantin A ^a   Herzog, Thomas J ^b   Alexandrescu, Doru T ^c  

^a SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^b New York Presbyterian Hospital ^*  (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Carboplatin; Dose reduction; Gemcitabine; Hematological toxicity; Ovarian cancer

Indexed keywords

CARBOPLATIN; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL;

ABDOMINAL HYSTERECTOMY; ADULT; ADVANCED CANCER; ANEMIA; AREA UNDER THE CURVE; ARTHRALGIA; ARTICLE; ASCITES; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPISTAXIS; FATIGUE; FEMALE; HUMAN; LEUKOPENIA; METASTASIS; MULTIPLE CYCLE TREATMENT; MYALGIA; NEUTROPENIA; OVARY CANCER; OVERALL SURVIVAL; PAPULOVESICULAR RASH; PERITONEUM CANCER; PLEURA EFFUSION; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; STEADY STATE; THERAPY DELAY; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ADENOCARCINOMA; ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; EPISTAXIS; FATIGUE; FEMALE; HUMANS; LEUKOPENIA; LIVER NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PELVIC NEOPLASMS; REMISSION INDUCTION; SPLENIC NEOPLASMS; THROMBOCYTOPENIA;

EID: 77749322178     PISSN: 10781552     EISSN: None     Source Type: Journal    
DOI: 10.1177/1078155209105396     Document Type: Article

References (11)

1. Lorusso D., Di Stefano A., Fanfani F., Scambia G. Role of gemcitabine in ovarian cancer treatment. Ann Oncol 2006 ; 17 (5). 188-194.
2. Poveda A. Gemcitabine in patients with ovarian cancer. Cancer Treat Rev 2005 ; 31 (4). S29-37.
3. Mutch DG Gemcitabine combination chemotherapy of ovarian cancer. Gynecol Oncol 2003 ; 90 (2 Pt 2). S16-20.
4. Kose MF, Meydanli MM, Tulunay G. Gemcitabine plus carboplatin in platinum-sensitive recurrent ovarian carcinoma. Expert Rev Anticancer Ther 2006 ; 6 (3). 437-443.
5. Kose MF, Sufliarsky J., Beslija S., Saip P., Tulunay G., Krejcy K. et al. A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma. Gynecol Oncol 2005 ; 96 (2). 374-380.
6. Tay SK, Ilanchadran A., Tan TY First-line gemcitabine and carboplatin in advanced ovarian carcinoma: a phase II study. BJOG 2006 ; 113 (12). 1388-1392.
7. Tassinari D., Fochessati F., Arcangeli V., Sartori S., Agostini V., Fantini M. et al. Carboplatin and gemcitabine in the palliative treatment of stage IV non-small cell lung cancer: definitive results of a phase II trial. Tumori 2004 ; 90 (1). 54-59.
8. Laessig D., Stemmler HJ, Vehling-Kaiser U., Fasching PA, Melchert F., Kolbl H. et al. Gemcitabine and carboplatin in intensively pretreated patients with metastatic breast cancer. Oncology 2007 ; 73 (5-6). 407-414. (Pubitemid 351862038)
9. Xiros N., Papacostas P., Economopoulos T., Samelis G., Efstathiou E., Kastritis E. et al. Carboplatin plus gemcitabine in patients with inoperable or metastatic pancreatic cancer: a phase II multicenter study by the Hellenic Cooperative Oncology Group. Ann Oncol 2005 ; 16 (5). 773-779.
10. Soo RA, Wang LZ, Tham LS, Yong WP, Boyer M., Lim HL et al. A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancer. Ann Oncol 2006 ; 17 (7). 1128-1133.
11. Richardson DL, Backes FJ, Seamon LG, Zanagnolo V., O'Malley DM, Cohn DE et al. Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer. Gynecol Oncol 2008 ; 111 (3). 461-466.